Search

Your search keyword '"Hayhow, Thomas G."' showing total 26 results

Search Constraints

Start Over You searched for: Author "Hayhow, Thomas G." Remove constraint Author: "Hayhow, Thomas G."
26 results on '"Hayhow, Thomas G."'

Search Results

1. Metabolism-driven in vitro/in vivo disconnect of an oral ERɑ VHL-PROTAC

2. Modulation of macrophage inflammatory function through selective inhibition of the epigenetic reader protein SP140

6. The design and synthesis of probe molecules to validate the inhibition of epigenetic mechanisms for phenotypic responses

7. Additional file 16 of Modulation of macrophage inflammatory function through selective inhibition of the epigenetic reader protein SP140

8. Design, Synthesis, and Characterization of I-BET567, a Pan-Bromodomain and Extra Terminal (BET) Bromodomain Oral Candidate

9. Template-Hopping Approach Leads to Potent, Selective, and Highly Soluble Bromo and Extraterminal Domain (BET) Second Bromodomain (BD2) Inhibitors

11. The Optimization of a Novel, Weak Bromo and Extra Terminal Domain (BET) Bromodomain Fragment Ligand to a Potent and Selective Second Bromodomain (BD2) Inhibitor

12. Discovery and In VivoEfficacy of AZ-PRMT5i-1, a Novel PRMT5 Inhibitor with High MTA Cooperativity

13. Discovery of a Potent, Cell Penetrant, and Selective p300/CBP-Associated Factor (PCAF)/General Control Nonderepressible 5 (GCN5) Bromodomain Chemical Probe

14. Cell Penetrant Inhibitors of the KDM4 and KDM5 Families of Histone Lysine Demethylases. 2. Pyrido[3,4-d]pyrimidin-4(3H)-one Derivatives

15. Cell Penetrant Inhibitors of the KDM4 and KDM5 Families of Histone Lysine Demethylases. 1. 3-Amino-4-pyridine Carboxylate Derivatives

16. Discovery of GSK143, a highly potent, selective and orally efficacious spleen tyrosine kinase inhibitor

20. Discovery of GSK345931A: An EP1 receptor antagonist with efficacy in preclinical models of inflammatory pain

21. Discovery of brain penetrant, soluble, pyrazole amide EP1 receptor antagonists

22. Non-acidic pyrazole EP1 receptor antagonists with in vivo analgesic efficacy

23. Discovery of GSK345931A: An EP1 receptor antagonist with efficacy in preclinical models of inflammatory pain

24. Discovery of brain penetrant, soluble, pyrazole amide EP1 receptor antagonists

25. Non-acidic pyrazole EP1 receptor antagonists with in vivo analgesic efficacy

26. A Buchwald-Hartwig Protocol to Enable Rapid Linker Exploration of Cereblon E3-Ligase PROTACs*.

Catalog

Books, media, physical & digital resources